365 related articles for article (PubMed ID: 14769933)
1. Mimicking live flavivirus immunization with a noninfectious RNA vaccine.
Kofler RM; Aberle JH; Aberle SW; Allison SL; Heinz FX; Mandl CW
Proc Natl Acad Sci U S A; 2004 Feb; 101(7):1951-6. PubMed ID: 14769933
[TBL] [Abstract][Full Text] [Related]
2. Flavivirus immunization with capsid-deletion mutants: basics, benefits, and barriers.
Mandl CW
Viral Immunol; 2004; 17(4):461-72. PubMed ID: 15671744
[TBL] [Abstract][Full Text] [Related]
3. Third-generation flavivirus vaccines based on single-cycle, encapsidation-defective viruses.
Widman DG; Frolov I; Mason PW
Adv Virus Res; 2008; 72():77-126. PubMed ID: 19081489
[TBL] [Abstract][Full Text] [Related]
4. Humoral and cellular immune response to RNA immunization with flavivirus replicons derived from tick-borne encephalitis virus.
Aberle JH; Aberle SW; Kofler RM; Mandl CW
J Virol; 2005 Dec; 79(24):15107-13. PubMed ID: 16306582
[TBL] [Abstract][Full Text] [Related]
5. Characterization of the RepliVax platform for replication-defective flavivirus vaccines.
Rumyantsev AA; Giel-Moloney M; Liu Y; Gao QS; Zhang ZX; Catalan J; Frolov I; Almond J; Kleanthous H; Pugachev KV
Vaccine; 2011 Jul; 29(32):5184-94. PubMed ID: 21620917
[TBL] [Abstract][Full Text] [Related]
6. Recombinant vector derived from live attenuated measles virus: potential for flavivirus vaccines.
Brandler S; Tangy F
Comp Immunol Microbiol Infect Dis; 2008 Mar; 31(2-3):271-91. PubMed ID: 17869338
[TBL] [Abstract][Full Text] [Related]
7. Single-round infectious particles enhance immunogenicity of a DNA vaccine against West Nile virus.
Chang DC; Liu WJ; Anraku I; Clark DC; Pollitt CC; Suhrbier A; Hall RA; Khromykh AA
Nat Biotechnol; 2008 May; 26(5):571-7. PubMed ID: 18425125
[TBL] [Abstract][Full Text] [Related]
8. Flavivirus DNA vaccines: current status and potential.
Chang GJ; Davis BS; Hunt AR; Holmes DA; Kuno G
Ann N Y Acad Sci; 2001 Dec; 951():272-85. PubMed ID: 11797784
[TBL] [Abstract][Full Text] [Related]
9. In vitro-synthesized infectious RNA as an attenuated live vaccine in a flavivirus model.
Mandl CW; Aberle JH; Aberle SW; Holzmann H; Allison SL; Heinz FX
Nat Med; 1998 Dec; 4(12):1438-40. PubMed ID: 9846585
[TBL] [Abstract][Full Text] [Related]
10. Recent advancement in flavivirus vaccine development.
Chang GJ; Kuno G; Purdy DE; Davis BS
Expert Rev Vaccines; 2004 Apr; 3(2):199-220. PubMed ID: 15056045
[TBL] [Abstract][Full Text] [Related]
11. Infectious cDNA clone of attenuated Langat tick-borne flavivirus (strain E5) and a 3' deletion mutant constructed from it exhibit decreased neuroinvasiveness in immunodeficient mice.
Pletnev AG
Virology; 2001 Apr; 282(2):288-300. PubMed ID: 11289811
[TBL] [Abstract][Full Text] [Related]
12. Flaviviruses and flavivirus vaccines.
Heinz FX; Stiasny K
Vaccine; 2012 Jun; 30(29):4301-6. PubMed ID: 22682286
[TBL] [Abstract][Full Text] [Related]
13. Replication/Assembly Defective Avian Flavivirus With Internal Deletions in the Capsid Can Be Used as an Approach for Living Attenuated Vaccine.
He Y; Wang X; Guo J; Mao L; Zhang S; Hu T; Wang M; Jia R; Zhu D; Liu M; Zhao X; Yang Q; Wu Y; Zhang S; Huang J; Mao S; Ou X; Gao Q; Sun D; Liu Y; Zhang L; Yu Y; Cheng A; Chen S
Front Immunol; 2021; 12():694959. PubMed ID: 34421904
[TBL] [Abstract][Full Text] [Related]
14. Construction and biological characterization of artificial recombinants between a wild type flavivirus (Kunjin) and a live chimeric flavivirus vaccine (ChimeriVax-JE).
Pugachev KV; Schwaiger J; Brown N; Zhang ZX; Catalan J; Mitchell FS; Ocran SW; Rumyantsev AA; Khromykh AA; Monath TP; Guirakhoo F
Vaccine; 2007 Sep; 25(37-38):6661-71. PubMed ID: 17693000
[TBL] [Abstract][Full Text] [Related]
15. Flavivirus DNA vaccines--good science, uncertain future.
Petersen LR; Roehrig JT
J Infect Dis; 2007 Dec; 196(12):1721-3. PubMed ID: 18190248
[No Abstract] [Full Text] [Related]
16. Advances in flavivirus vaccine development.
Coller BA; Clements DE; Martyak T; Yelmene M; Thorne M; Parks DE
IDrugs; 2010 Dec; 13(12):880-4. PubMed ID: 21154147
[TBL] [Abstract][Full Text] [Related]
17. Safety concerns with regard to live attenuated flavivirus vaccines.
Seligman SJ; Gould EA
J Infect Dis; 2008 Sep; 198(5):794-5. PubMed ID: 18694340
[No Abstract] [Full Text] [Related]
18. Live measles vaccine expressing the secreted form of the West Nile virus envelope glycoprotein protects against West Nile virus encephalitis.
Desprès P; Combredet C; Frenkiel MP; Lorin C; Brahic M; Tangy F
J Infect Dis; 2005 Jan; 191(2):207-14. PubMed ID: 15609230
[TBL] [Abstract][Full Text] [Related]
19. Comparative analysis of immunoglobulin M (IgM) capture enzyme-linked immunosorbent assay using virus-like particles or virus-infected mouse brain antigens to detect IgM antibody in sera from patients with evident flaviviral infections.
Holmes DA; Purdy DE; Chao DY; Noga AJ; Chang GJ
J Clin Microbiol; 2005 Jul; 43(7):3227-36. PubMed ID: 16000440
[TBL] [Abstract][Full Text] [Related]
20. Development of a live attenuated vaccine candidate against duck Tembusu viral disease.
Li G; Gao X; Xiao Y; Liu S; Peng S; Li X; Shi Y; Zhang Y; Yu L; Wu X; Yan P; Yan L; Teng Q; Tong G; Li Z
Virology; 2014 Feb; 450-451():233-42. PubMed ID: 24503086
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
